APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Medical Data Annotation Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Medical Data Annotation Service Market Outlook and Growth Opportunities 2026

Report ID 17418487042 May 2026198 pages

Choose your research edition.

Industry ResearchMedical Data Annotation Service Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Data Annotation Service Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Medical Data Annotation Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Data Annotation Service Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Data Annotation Service Market Analysis and Forecast 2026-2032230 pages · $4,950 USD

Market perspective

The global Medical Data Annotation Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Medical Data Annotation Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Medical Data Annotation Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medical Data Annotation Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Medical Data Annotation Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Medical Data Annotation Service market include Annotation Box, Anolytics, Supervisely, Cogito Tech, Infosys BPM, Innodata, Keymakr, Labelbox and Labellerr, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Medical Data Annotation Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Medical Data Annotation Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medical Data Annotation Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Medical Data Annotation Service market.

Medical Data Annotation Service Segment by Company

Annotation Box

Anolytics

Supervisely

Cogito Tech

Infosys BPM

Innodata

Keymakr

Labelbox

Labellerr

Linh AI

Shaip

Smartone

SO Development

Medical Data Annotation Service Segment by Type

Image Segmentation

Image Classification

Polygonal Annotation

Bounding Box Annotation

Medical Data Annotation Service Segment by Application

Image Data

Text Data

Video Data

Others

Medical Data Annotation Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Medical Data Annotation Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Medical Data Annotation Service key companies, revenue, market share, and recent developments.

3. To split the Medical Data Annotation Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Medical Data Annotation Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Medical Data Annotation Service significant trends, drivers, influence factors in global and regions.

6. To analyze Medical Data Annotation Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Data Annotation Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Data Annotation Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Data Annotation Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Data Annotation Service industry.

Chapter 3: Detailed analysis of Medical Data Annotation Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Medical Data Annotation Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Medical Data Annotation Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Medical Data Annotation Service Industry Trends Table 2. Medical Data Annotation Service Industry Drivers Table 3. Medical Data Annotation Service Industry Opportunities and Challenges Table 4. Medical Data Annotation Service Industry Restraints Table 5. Global Medical Data Annotation Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Medical Data Annotation Service Revenue Share by Company (2021-2026) Table 7. Global Medical Data Annotation Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Medical Data Annotation Service Key Company Manufacturing Base & Headquarters Table 9. Global Medical Data Annotation Service Company, Product Type & Application Table 10. Global Medical Data Annotation Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Medical Data Annotation Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Image Segmentation Table 15. Significant Companies of Image Classification Table 16. Significant Companies of Polygonal Annotation Table 17. Significant Companies of Bounding Box Annotation Table 18. Global Medical Data Annotation Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Medical Data Annotation Service Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Medical Data Annotation Service Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Medical Data Annotation Service Sales Value Share by Type (2021-2026) Table 22. Global Medical Data Annotation Service Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Image Data Table 24. Significant Companies of Text Data Table 25. Significant Companies of Video Data Table 26. Significant Companies of Others Table 27. Global Medical Data Annotation Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Medical Data Annotation Service Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Medical Data Annotation Service Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Medical Data Annotation Service Sales Value Share by Application (2021-2026) Table 31. Global Medical Data Annotation Service Sales Value Share by Application (2027-2032) Table 32. Global Medical Data Annotation Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Medical Data Annotation Service Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Medical Data Annotation Service Sales Value Share by Region (2021-2026) Table 35. Global Medical Data Annotation Service Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Medical Data Annotation Service Sales Value Share by Region (2027-2032) Table 37. Global Medical Data Annotation Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Medical Data Annotation Service Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Medical Data Annotation Service Sales Value Market Share by Country (2021-2026) Table 40. Global Medical Data Annotation Service Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Medical Data Annotation Service Sales Value Market Share by Country (2027-2032) Table 42. Annotation Box Company Information Table 43. Annotation Box Business Overview Table 44. Annotation Box Medical Data Annotation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Annotation Box Medical Data Annotation Service Product Portfolio Table 46. Annotation Box Recent Development Table 47. Anolytics Company Information Table 48. Anolytics Business Overview Table 49. Anolytics Medical Data Annotation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Anolytics Medical Data Annotation Service Product Portfolio Table 51. Anolytics Recent Development Table 52. Supervisely Company Information Table 53. Supervisely Business Overview Table 54. Supervisely Medical Data Annotation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Supervisely Medical Data Annotation Service Product Portfolio Table 56. Supervisely Recent Development Table 57. Cogito Tech Company Information Table 58. Cogito Tech Business Overview Table 59. Cogito Tech Medical Data Annotation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Cogito Tech Medical Data Annotation Service Product Portfolio Table 61. Cogito Tech Recent Development Table 62. Infosys BPM Company Information Table 63. Infosys BPM Business Overview Table 64. Infosys BPM Medical Data Annotation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Infosys BPM Medical Data Annotation Service Product Portfolio Table 66. Infosys BPM Recent Development Table 67. Innodata Company Information Table 68. Innodata Business Overview Table 69. Innodata Medical Data Annotation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Innodata Medical Data Annotation Service Product Portfolio Table 71. Innodata Recent Development Table 72. Keymakr Company Information Table 73. Keymakr Business Overview Table 74. Keymakr Medical Data Annotation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Keymakr Medical Data Annotation Service Product Portfolio Table 76. Keymakr Recent Development Table 77. Labelbox Company Information Table 78. Labelbox Business Overview Table 79. Labelbox Medical Data Annotation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Labelbox Medical Data Annotation Service Product Portfolio Table 81. Labelbox Recent Development Table 82. Labellerr Company Information Table 83. Labellerr Business Overview Table 84. Labellerr Medical Data Annotation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Labellerr Medical Data Annotation Service Product Portfolio Table 86. Labellerr Recent Development Table 87. Linh AI Company Information Table 88. Linh AI Business Overview Table 89. Linh AI Medical Data Annotation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Linh AI Medical Data Annotation Service Product Portfolio Table 91. Linh AI Recent Development Table 92. Shaip Company Information Table 93. Shaip Business Overview Table 94. Shaip Medical Data Annotation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Shaip Medical Data Annotation Service Product Portfolio Table 96. Shaip Recent Development Table 97. Smartone Company Information Table 98. Smartone Business Overview Table 99. Smartone Medical Data Annotation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Smartone Medical Data Annotation Service Product Portfolio Table 101. Smartone Recent Development Table 102. SO Development Company Information Table 103. SO Development Business Overview Table 104. SO Development Medical Data Annotation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. SO Development Medical Data Annotation Service Product Portfolio Table 106. SO Development Recent Development Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Medical Data Annotation Service Product Image Figure 2. Global Medical Data Annotation Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Data Annotation Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Medical Data Annotation Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Image Segmentation Image Figure 8. Image Classification Image Figure 9. Polygonal Annotation Image Figure 10. Bounding Box Annotation Image Figure 11. Global Medical Data Annotation Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Medical Data Annotation Service Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Medical Data Annotation Service Sales Value Share by Type (2021-2032) Figure 14. Image Data Image Figure 15. Text Data Image Figure 16. Video Data Image Figure 17. Others Image Figure 18. Global Medical Data Annotation Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Medical Data Annotation Service Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Medical Data Annotation Service Sales Value Share by Application (2021-2032) Figure 21. Global Medical Data Annotation Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Medical Data Annotation Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Medical Data Annotation Service Sales Value (2021-2032) & (US$ Million) Figure 24. North America Medical Data Annotation Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Medical Data Annotation Service Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Medical Data Annotation Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Medical Data Annotation Service Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Medical Data Annotation Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Medical Data Annotation Service Sales Value (2021-2032) & (US$ Million) Figure 30. South America Medical Data Annotation Service Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Medical Data Annotation Service Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Medical Data Annotation Service Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Medical Data Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Medical Data Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Medical Data Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Medical Data Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Medical Data Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Medical Data Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Medical Data Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Medical Data Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Medical Data Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Medical Data Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Medical Data Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Medical Data Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Medical Data Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Medical Data Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Medical Data Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Medical Data Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Medical Data Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Medical Data Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Medical Data Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Medical Data Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Medical Data Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Medical Data Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Medical Data Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Medical Data Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Medical Data Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Medical Data Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Medical Data Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Medical Data Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Image Segmentation
  • Image Classification
  • Polygonal Annotation
  • Bounding Box Annotation
Applications
  • Image Data
  • Text Data
  • Video Data
  • Others
Companies covered
  • Annotation Box
  • Anolytics
  • Supervisely
  • Cogito Tech
  • Infosys BPM
  • Innodata
  • Keymakr
  • Labelbox
  • Labellerr
  • Linh AI
  • Shaip
  • Smartone
  • SO Development

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Medical Data Annotation Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Medical Data Annotation Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Medical Data Annotation Service Market Dynamics
  1. 2.1 Medical Data Annotation Service Industry Trends
  2. 2.2 Medical Data Annotation Service Industry Drivers
  3. 2.3 Medical Data Annotation Service Industry Opportunities and Challenges
  4. 2.4 Medical Data Annotation Service Industry Restraints
3 Medical Data Annotation Service Market by Company
  1. 3.1 Global Medical Data Annotation Service Company Revenue Ranking in 2025
  2. 3.2 Global Medical Data Annotation Service Revenue by Company (2021-2026)
  3. 3.3 Global Medical Data Annotation Service Company Ranking (2024-2026)
  4. 3.4 Global Medical Data Annotation Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Medical Data Annotation Service Company Product Type and Application
  6. 3.6 Global Medical Data Annotation Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Medical Data Annotation Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Medical Data Annotation Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Medical Data Annotation Service Market by Type
  1. 4.1 Medical Data Annotation Service Type Introduction
  2. 4.1.1 Image Segmentation
  3. 4.1.2 Image Classification
  4. 4.1.3 Polygonal Annotation
  5. 4.1.4 Bounding Box Annotation
  6. 4.2 Global Medical Data Annotation Service Sales Value by Type
  7. 4.2.1 Global Medical Data Annotation Service Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Medical Data Annotation Service Sales Value by Type (2021-2032)
  9. 4.2.3 Global Medical Data Annotation Service Sales Value Share by Type (2021-2032)
5 Medical Data Annotation Service Market by Application
  1. 5.1 Medical Data Annotation Service Application Introduction
  2. 5.1.1 Image Data
  3. 5.1.2 Text Data
  4. 5.1.3 Video Data
  5. 5.1.4 Others
  6. 5.2 Global Medical Data Annotation Service Sales Value by Application
  7. 5.2.1 Global Medical Data Annotation Service Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Medical Data Annotation Service Sales Value by Application (2021-2032)
  9. 5.2.3 Global Medical Data Annotation Service Sales Value Share by Application (2021-2032)
6 Medical Data Annotation Service Regional Value Analysis
  1. 6.1 Global Medical Data Annotation Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Medical Data Annotation Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Medical Data Annotation Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Medical Data Annotation Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Medical Data Annotation Service Sales Value (2021-2032)
  7. 6.3.2 North America Medical Data Annotation Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Medical Data Annotation Service Sales Value (2021-2032)
  10. 6.4.2 Europe Medical Data Annotation Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Medical Data Annotation Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Medical Data Annotation Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Medical Data Annotation Service Sales Value (2021-2032)
  16. 6.6.2 South America Medical Data Annotation Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Medical Data Annotation Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Medical Data Annotation Service Sales Value Share by Country, 2025 VS 2032
7 Medical Data Annotation Service Country-level Value Analysis
  1. 7.1 Global Medical Data Annotation Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Medical Data Annotation Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Medical Data Annotation Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Medical Data Annotation Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Medical Data Annotation Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Medical Data Annotation Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Medical Data Annotation Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Medical Data Annotation Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Medical Data Annotation Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Medical Data Annotation Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Medical Data Annotation Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Medical Data Annotation Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Medical Data Annotation Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Medical Data Annotation Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Medical Data Annotation Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Medical Data Annotation Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Medical Data Annotation Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Medical Data Annotation Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Medical Data Annotation Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Medical Data Annotation Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Medical Data Annotation Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Medical Data Annotation Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Medical Data Annotation Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Medical Data Annotation Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Medical Data Annotation Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Medical Data Annotation Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Medical Data Annotation Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Medical Data Annotation Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Medical Data Annotation Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Medical Data Annotation Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Medical Data Annotation Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Medical Data Annotation Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Medical Data Annotation Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Medical Data Annotation Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Annotation Box
  2. 8.1.1 Annotation Box Company Information
  3. 8.1.2 Annotation Box Business Overview
  4. 8.1.3 Annotation Box Medical Data Annotation Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Annotation Box Medical Data Annotation Service Product Portfolio
  6. 8.1.5 Annotation Box Recent Developments
  7. 8.2 Anolytics
  8. 8.2.1 Anolytics Company Information
  9. 8.2.2 Anolytics Business Overview
  10. 8.2.3 Anolytics Medical Data Annotation Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Anolytics Medical Data Annotation Service Product Portfolio
  12. 8.2.5 Anolytics Recent Developments
  13. 8.3 Supervisely
  14. 8.3.1 Supervisely Company Information
  15. 8.3.2 Supervisely Business Overview
  16. 8.3.3 Supervisely Medical Data Annotation Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Supervisely Medical Data Annotation Service Product Portfolio
  18. 8.3.5 Supervisely Recent Developments
  19. 8.4 Cogito Tech
  20. 8.4.1 Cogito Tech Company Information
  21. 8.4.2 Cogito Tech Business Overview
  22. 8.4.3 Cogito Tech Medical Data Annotation Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Cogito Tech Medical Data Annotation Service Product Portfolio
  24. 8.4.5 Cogito Tech Recent Developments
  25. 8.5 Infosys BPM
  26. 8.5.1 Infosys BPM Company Information
  27. 8.5.2 Infosys BPM Business Overview
  28. 8.5.3 Infosys BPM Medical Data Annotation Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Infosys BPM Medical Data Annotation Service Product Portfolio
  30. 8.5.5 Infosys BPM Recent Developments
  31. 8.6 Innodata
  32. 8.6.1 Innodata Company Information
  33. 8.6.2 Innodata Business Overview
  34. 8.6.3 Innodata Medical Data Annotation Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Innodata Medical Data Annotation Service Product Portfolio
  36. 8.6.5 Innodata Recent Developments
  37. 8.7 Keymakr
  38. 8.7.1 Keymakr Company Information
  39. 8.7.2 Keymakr Business Overview
  40. 8.7.3 Keymakr Medical Data Annotation Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Keymakr Medical Data Annotation Service Product Portfolio
  42. 8.7.5 Keymakr Recent Developments
  43. 8.8 Labelbox
  44. 8.8.1 Labelbox Company Information
  45. 8.8.2 Labelbox Business Overview
  46. 8.8.3 Labelbox Medical Data Annotation Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Labelbox Medical Data Annotation Service Product Portfolio
  48. 8.8.5 Labelbox Recent Developments
  49. 8.9 Labellerr
  50. 8.9.1 Labellerr Company Information
  51. 8.9.2 Labellerr Business Overview
  52. 8.9.3 Labellerr Medical Data Annotation Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Labellerr Medical Data Annotation Service Product Portfolio
  54. 8.9.5 Labellerr Recent Developments
  55. 8.10 Linh AI
  56. 8.10.1 Linh AI Company Information
  57. 8.10.2 Linh AI Business Overview
  58. 8.10.3 Linh AI Medical Data Annotation Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Linh AI Medical Data Annotation Service Product Portfolio
  60. 8.10.5 Linh AI Recent Developments
  61. 8.11 Shaip
  62. 8.11.1 Shaip Company Information
  63. 8.11.2 Shaip Business Overview
  64. 8.11.3 Shaip Medical Data Annotation Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Shaip Medical Data Annotation Service Product Portfolio
  66. 8.11.5 Shaip Recent Developments
  67. 8.12 Smartone
  68. 8.12.1 Smartone Company Information
  69. 8.12.2 Smartone Business Overview
  70. 8.12.3 Smartone Medical Data Annotation Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Smartone Medical Data Annotation Service Product Portfolio
  72. 8.12.5 Smartone Recent Developments
  73. 8.13 SO Development
  74. 8.13.1 SO Development Company Information
  75. 8.13.2 SO Development Business Overview
  76. 8.13.3 SO Development Medical Data Annotation Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 SO Development Medical Data Annotation Service Product Portfolio
  78. 8.13.5 SO Development Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst